Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: A report of four cases

Lancet

Volumn 358, Issue 9276, 2001, Pages 98-104

  Martin, Michael ^a,c   Tsai, Theodore F ^b   Cropp, Bruce ^b   Chang, Gwong Jen J ^b   Holmes, Derek A ^b   Tseng, Jennifer ^b   Shieh, Wun Ju ^a   Zaki, Sherif R ^a   Al Sanouri, Ibrahim ^d   Cutrona, Anthony F ^d   Ray, Glenn ^d   Weld, Leisa H ^a   Cetron, Martin S ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Western Reserve Care System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIGEN; YELLOW FEVER VACCINE; YELLOW FEVER VIRUS 17D 204 VACCINE; YELLOW FEVER VIRUS ANTIGEN;

ADULT; AFRICA; AGED; ANALYTIC METHOD; ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CASE REPORT; CEREBROSPINAL FLUID; CLINICAL FEATURE; CONVALESCENCE; DEATH; FEMALE; FEVER; GENE SEQUENCE; HUMAN; HUMAN TISSUE; KUPFFER CELL; LIVER; MALE; MULTIPLE ORGAN FAILURE; PLASMA; PRIORITY JOURNAL; SOUTH AMERICA; VACCINATION; VIRUS CHARACTERIZATION; VIRUS ISOLATION; VIRUS STRAIN; YELLOW FEVER FLAVIVIRUS;

EID: 0035859509     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)05327-2     Document Type: Article

References (25)

1. Clinical manifestations of yellow fever in the West African native as observed during four extensive epidemics of the disease in the Gold Coast and Nigeria
2. Epidemic yellow fever in eastern Nigeria, 1986
3. Observations on the age and sex incidence of deaths and recoveries in the yellow fever epidemic in the department of Lambayeque, Peru, in 1921
4. An epidemic of yellow fever in the Nuba mountains, Anglo-Egyptian Sudan
5. Yellow fever outbreak in Kaffrine, Senegal 1996: Epidemiological and entomological findings
6. Yellow fever
7. Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine
8. Use of a monoclonal antibody specific for wild-type yellow fever virus to identify a wild-type antigenic variant in 17D vaccine pools
9. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease
10. Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213
11. Possible association of encephalitis and 17D yellow fever vaccination in a 29-year-old traveler
12. Yellow fever vaccination with cultured virus (17D) without immune serum
13. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution
14. Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice
15. Fatal viral encephalitis following 17D yellow fever vaccine inoculation
16. Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis
17. Flaviviruses
18. Advanced age as a risk factor for adverse events temporally associated with yellow fever vaccination
19. Serious adverse events associated with yellow fever 17DD vaccine in Brazil: A report of two cases
20. Imported yellow fever in a United States citizen
21. Jungle yellow fever in the central Amazon
22. A haemorrhagic fever from the Cote d'Ivoire
23. Fatal yellow fever in a traveler returning from Venezuela, 1999